/
/
/

Astal Laboratories Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Mar 2025
₹101 Cr₹134 Cr₹23 Cr
₹14 L₹10 L₹4 L
₹101 Cr₹134 Cr₹24 Cr
₹90 Cr₹125 Cr₹19 Cr
₹12 Cr₹10 Cr₹4 Cr
₹1 Cr₹1 Cr₹27 L
₹10 Cr₹8 Cr₹4 Cr
₹9 Cr₹8 Cr₹3 Cr

Share Price Live Stats

Open (₹)51.85
Volume (₹)36,632.00
High (₹)58.45
Upper Circuit61.50
Low (₹)51.00
Lower Circuit41.00
Prev Close51.25
52W High (₹)99.90
Price54.85
52W Low (₹)49.99

Share Market Cap & Key Ratios Overview

M.Cap (₹)224.47 Cr
Div. Yield (%)0.00
PE Ratio15.26
Debt to Equity0.15
Price to Book0.83
Book Value78.57
EPS (TTM)3.36
Face Value10.00
ROE (%)8.08

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
ASTALLTD-XNSE
LTP
1W Low
1W High
Market cap (₹)
1795.45+17.2 (0.97%)
1720.80
1809.65
4,25,150Cr
10005+290 (2.99%)
9866.35
10080.20
2,66,265Cr
4682.45+47.3 (1.02%)
4555
4695
1,76,301Cr
2320.95-71.05 (-2.97%)
2252.50
2442
1,25,352Cr
1184.25-59.75 (-4.80%)
1184
1266.15
1,23,591Cr
1366+15.8 (1.17%)
1337.30
1390.70
1,14,351Cr
1389.9+9.9 (0.72%)
1364.75
1400.60
1,12,474Cr
2482.6-6.15 (-0.25%)
2457.35
2523.70
1,02,315Cr
1711.55+33.75 (2.01%)
1656.90
1714
97,757Cr
2029.9+20.9 (1.04%)
1989.10
2061.55
92,007Cr
54.85-6.85 (-11.10%)
49.99
62.90
224Cr
Empty box

No content available